Haisco Pharmaceutical Group Nachrichten

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• Lilly’s latest China drug deal; Immunovant’s setback in lupus (öffnet in neuem Tab)

  24.09.2026

• 
  AirNexis Therapeutics Announces that AN01, a Dual PDE3/4 Inhibitor Dry Powder Inhaler (DPI) Met its Primary Endpoint in a Phase 2b COPD Study (HSK39004-T1-202) Conducted in China by AirNexis' partner Haisco Pharmaceutical Group (öffnet in neuem Tab)

  GlobeNewswire · 08.09.2026

• 
  Haisco enters into Exclusive License Agreement with new US venture founded by Population Health Partners and ARCH Venture Partners (öffnet in neuem Tab)

  PR Newswire · 25.08.2026

• 
  Nuvectis Stock Surges Around 97% in 3 Months: Here's Why (öffnet in neuem Tab)

  Zacks · 19.08.2026

• Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights (öffnet in neuem Tab)

  04.08.2026

• 
  StreetWatch: Nuvectis Pharma Eyes $9.8 Billion Oral PNH Market With Late-Stage NXP100 Backed by Strong Positive Phase 3 Data (öffnet in neuem Tab)

  TMX Newsfile · 14.07.2026

• 
  Haisco and Nuvectis sign licensing deal for two drugs (öffnet in neuem Tab)

  Hospital Management · 24.06.2026

• Haisco Enters into Exclusive License Agreement with Nuvectis for Two Drug Candidates in Oncology and Complement Indications (öffnet in neuem Tab)

  23.06.2026

• 
  Nuvectis Expands Pipeline with Haisco Licensing Agreement for Two Clinical-Stage Drug Candidates (NVCT) (öffnet in neuem Tab)

  InvestorsHub · 22.06.2026

• 
  Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds (öffnet in neuem Tab)

  GlobeNewswire · 22.06.2026

• 
  Eli Lilly Expands Beyond Obesity With US$4b Vaccine And Genetic Bets (öffnet in neuem Tab)

  Simply Wall St. · 07.06.2026

• 
  Eli Lilly Broadens Beyond Obesity Drugs With Vaccine And Genetic Bets (öffnet in neuem Tab)

  Simply Wall St. · 06.06.2026

• Eli Lilly Deepens Innovation Push Through New Biopharma Collaborations (öffnet in neuem Tab)

  03.06.2026

• 
  Haisco Announces Licensing and Research Collaboration Agreement with Lilly to Develop Innovative Medicines Across Multiple Therapeutic Areas (öffnet in neuem Tab)

  PR Newswire · 01.06.2026

• 
  AbbVie Inc. (ABBV) Inks Licensing Agreement for Pain Medicines Development (öffnet in neuem Tab)

  Insider Monkey · 22.04.2026

• Haisco Grants Global Rights of Innovative Drug HSK39004 to AirNexis in Deal Exceeding USD 1 Billion (öffnet in neuem Tab)

  12.01.2026